Global
Search    
Include All CSL Behring Country Sites

Therapies

Lab workers at CSL Behring use the latest technologies to produce coagulation therapies including Nanofiltration Berns.
Therapies we provide
CSL Behring biotherapies replace missing components in the blood and are indicated for the treatment of rare diseases such as hemophilia and other coagulation disorders, primary immune deficiencies and inherited respiratory disease. Biotherapies also prevent Rh-factor problems in newborns, speed recovery from heart surgery and help victims of shock of burns recover faster.

Our biotherapies target five therapeutic areas: